COVID-19 IgM IgG Antibody Rapid Test Kit 10 Tests Lateral Flow CE NMPA
Rapid 1-15 min visual results for IgM and IgG antibodies. Validated with clinical samples, CE and NMPA approved. Ideal complement to RT-PCR for COVID-19 diagnosis. Sensitivity 90.6%, specificity 99.2%. Easy to use on site.
15Min IgM IgG Test Kit
Introduction
Whole Blood, Serum and Plasma Sample Types
Result in 1-15min visually
Independent IgM and IgG results
Validated by Hundreds of Clinical Samples
CFDA/NMPA approved, CE labeled
Feature
Rapid and Easy to Use,Auxiliary test for the diagnosis of COVID-19
Ideal complement to coronavirus nucleic acid tests (RT-PCR etc.) to avoid misdiagnosis
Independent IgM and IgG results in one kit, capable for confirmation of COVID-19
(according to the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia 7th Edition by the National Health Commission of P.R.China)
Much easier and faster way to test people on site
Possible to find asymptomatic carriers and to confirm hospital discharge
Parameters
| Manufacture | ZHUHAI LIVZON DIAGNOSTICS INC. | |
| Address | Building 1 No. 266 Tongchang Road, Xiangzhou District, 519060 Zhuhai, Guangdong, P. R. China | |
| Product Name | The Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) | |
| Model | 10 Test sets /kit; 20 Tests sets/kits | |
| Features | 1.Result in 1-15min visually 2, single detection, separate detection of IgM and IgG, the two results are non-interference and can complement each other 3, IgM and IgG combined sensitivity and specificity is 90.6% and 99.2% respectively. Total accordance rate equals 95.3%. |
|
| Registration certificate No. | National Medical Products Administration approval No.20203400240 | |
| Package | Color box | |
| Place of Origin | China (Mainland) | |
| Validity Period | One year | |
| Storage temperature | 2-30℃ | |
| Applications | Suspected case test in epidemic area, early test of fever clinic and CDC, screening of primary medical institutions, inspecton of floating population in railway station and airports. | |
Application
Suspected case test in epidemic area, early test of fever clinic and CDC, screening of primary medical institutions, inspecton of floating population in railway station and airports.
Details
Recommended Products
